These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


446 related items for PubMed ID: 10102616

  • 1. Renal cell carcinoma of end-stage renal disease: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification.
    Hughson MD, Bigler S, Dickman K, Kovacs G.
    Mod Pathol; 1999 Mar; 12(3):301-9. PubMed ID: 10102616
    [Abstract] [Full Text] [Related]

  • 2. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD, Eble JN, Wang M, MacLennan GT, Delahunt B, Brunelli M, Martignoni G, Lopez-Beltran A, Bonsib SM, Ulbright TM, Zhang S, Nigro K, Cheng L.
    Clin Cancer Res; 2005 Oct 15; 11(20):7226-33. PubMed ID: 16243792
    [Abstract] [Full Text] [Related]

  • 3. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
    Thrash-Bingham CA, Salazar H, Freed JJ, Greenberg RE, Tartof KD.
    Cancer Res; 1995 Dec 15; 55(24):6189-95. PubMed ID: 8521412
    [Abstract] [Full Text] [Related]

  • 4. Histopathological, cytogenetic, and molecular characterization of renal cortical tumors.
    Presti JC, Rao PH, Chen Q, Reuter VE, Li FP, Fair WR, Jhanwar SC.
    Cancer Res; 1991 Mar 01; 51(5):1544-52. PubMed ID: 1671759
    [Abstract] [Full Text] [Related]

  • 5. Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity.
    Gobbo S, Eble JN, Grignon DJ, Martignoni G, MacLennan GT, Shah RB, Zhang S, Brunelli M, Cheng L.
    Am J Surg Pathol; 2008 Aug 01; 32(8):1239-45. PubMed ID: 18594469
    [Abstract] [Full Text] [Related]

  • 6. Molecular analysis of genetic changes in the origin and development of renal cell carcinoma.
    Anglard P, Tory K, Brauch H, Weiss GH, Latif F, Merino MJ, Lerman MI, Zbar B, Linehan WM.
    Cancer Res; 1991 Feb 15; 51(4):1071-7. PubMed ID: 1671754
    [Abstract] [Full Text] [Related]

  • 7. Interphase cytogenetics of multicentric renal cell tumours confirm associations of specific aberrations with defined cytomorphologies.
    Amo-Takyi BK, Mittermayer C, Günther K, Handt S.
    Br J Cancer; 2000 Apr 15; 82(8):1407-14. PubMed ID: 10780519
    [Abstract] [Full Text] [Related]

  • 8. Clear-cell and papillary carcinoma of the kidney: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification, cytogenetics, and fluorescence in situ hybridization.
    Hughson MD, Dickman K, Bigler SA, Meloni AM, Sandberg AA.
    Cancer Genet Cytogenet; 1998 Oct 15; 106(2):93-104. PubMed ID: 9797772
    [Abstract] [Full Text] [Related]

  • 9. Fluorescent microsatellite analysis reveals duplication of specific chromosomal regions in papillary renal cell tumors.
    Palmedo G, Fischer J, Kovacs G.
    Lab Invest; 1997 Dec 15; 77(6):633-8. PubMed ID: 9426401
    [Abstract] [Full Text] [Related]

  • 10. PCR-based RFLP screening of the commonly deleted 3p loci in renal cortical neoplasms.
    el-Naggar AK, Batsakis JG, Wang G, Lee MS.
    Diagn Mol Pathol; 1993 Dec 15; 2(4):269-76. PubMed ID: 7906993
    [Abstract] [Full Text] [Related]

  • 11. Metanephric adenoma lacks the gains of chromosomes 7 and 17 and loss of Y that are typical of papillary renal cell carcinoma and papillary adenoma.
    Brunelli M, Eble JN, Zhang S, Martignoni G, Cheng L.
    Mod Pathol; 2003 Oct 15; 16(10):1060-3. PubMed ID: 14559991
    [Abstract] [Full Text] [Related]

  • 12. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
    Zhou M, Yang XJ, Lopez JI, Shah RB, Hes O, Shen SS, Li R, Yang Y, Lin F, Elson P, Sercia L, Magi-Galluzzi C, Tubbs R.
    Am J Surg Pathol; 2009 Dec 15; 33(12):1840-9. PubMed ID: 19898225
    [Abstract] [Full Text] [Related]

  • 13. Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: importance of 1q and 3p copy number changes in metastatic events.
    Gronwald J, Störkel S, Holtgreve-Grez H, Hadaczek P, Brinkschmidt C, Jauch A, Lubinski J, Cremer T.
    Cancer Res; 1997 Feb 01; 57(3):481-7. PubMed ID: 9012478
    [Abstract] [Full Text] [Related]

  • 14. Nonpapillary and papillary renal cell carcinoma: a cytogenetic and phenotypic study.
    Hughson MD, Johnson LD, Silva FG, Kovacs G.
    Mod Pathol; 1993 Jul 01; 6(4):449-56. PubMed ID: 8415591
    [Abstract] [Full Text] [Related]

  • 15. Loss of heterozygosity at chromosomes 8p, 9p, and 14q is associated with stage and grade of non-papillary renal cell carcinomas.
    Schullerus D, Herbers J, Chudek J, Kanamaru H, Kovacs G.
    J Pathol; 1997 Oct 01; 183(2):151-5. PubMed ID: 9390026
    [Abstract] [Full Text] [Related]

  • 16. [Genetic aspects of renal tumors in adults].
    Fournet JC, Béroud C, Austruy E, Léonard C.
    Arch Anat Cytol Pathol; 1992 Oct 01; 40(5-6):301-6. PubMed ID: 1304117
    [Abstract] [Full Text] [Related]

  • 17. Correlations of allelic imbalance of chromosome 14 with adverse prognostic parameters in 148 renal cell carcinomas.
    Béroud C, Fournet JC, Jeanpierre C, Droz D, Bouvier R, Froger D, Chrétien Y, Maréchal JM, Weissenbach J, Junien C.
    Genes Chromosomes Cancer; 1996 Dec 01; 17(4):215-24. PubMed ID: 8946203
    [Abstract] [Full Text] [Related]

  • 18. Cytogenetic analysis in renal cell carcinoma: correlation with tumor aggressiveness.
    Weaver DJ, Michalski K, Miles J.
    Cancer Res; 1988 May 15; 48(10):2887-9. PubMed ID: 3359445
    [Abstract] [Full Text] [Related]

  • 19. Detection of deletions in the short arm of chromosome 3 in uncultured renal cell carcinomas by interphase cytogenetics.
    Siebert R, Jacobi C, Matthiesen P, Zühlke-Jenisch R, Potratz C, Zhang Y, Stöckle M, Klöppel G, Grote W, Schlegelberger B.
    J Urol; 1998 Aug 15; 160(2):534-9. PubMed ID: 9679924
    [Abstract] [Full Text] [Related]

  • 20. Clonal divergence and genetic heterogeneity in clear cell renal cell carcinomas with sarcomatoid transformation.
    Jones TD, Eble JN, Wang M, Maclennan GT, Jain S, Cheng L.
    Cancer; 2005 Sep 15; 104(6):1195-203. PubMed ID: 16047350
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.